• Login
    • Join
  • FOLLOW:
  • Subscribe Free
    • Magazine
    • eNewsletter
    Checkout
    • Magazine
    • News
    • Manufacturing
    • Packaging
    • Development
    • Compliance
    • Top 25
    • Directory
    • Microsites
    • Events
    • More
  • Magazine
  • News
  • Manufacturing
  • Packaging
  • Development
  • Compliance
  • Top 25
  • Directory
  • Microsites
  • Events
  • Current / Back Issue
    Features
    Editorial
    Columns
    Digital Edition
    eNewsletter Archive
    Our Team
    Editorial Guidelines
    Subscribe Now
    Advertise Now
    Top Features
    Hygienic Packaging Technology

    Trends in Solid Oral Dosage Delivery

    5 Reasons Paper Has No Place in Contract Manufacturing

    Injectable Drug Delivery Trends

    Pharmaceutical Manufacturing Equipment Trends
    Breaking News
    Online Exclusives
    Industry News
    Collaborations & Alliances
    Promotions & Moves
    Trials & Filings
    Financial Reports
    Bio News & Views
    Custom Sourcing News
    Packaging & Tracking
    CRO News
    Live From Shows
    Top News
    AGC Biologics Expands Cell and Gene Facility in Italy

    Celonic to Boost Cell & Gene Therapy Production

    Pharmaron Acquires Biomanufacturing Site in the UK from AbbVie

    Aptamer Extends Collaboration with AstraZeneca

    Fujifilm Breaks Ground on Major Expansion of Biologics Facility in Denmark
    APIs
    Aseptic Processing
    Cleaning Validation
    Clinical Trial Materials
    Cytotoxics and High Potency Manufacturing
    Equipment
    Excipients
    Extractables and Leachables
    Facilities
    Fill/Finish
    Lyophilization
    Parenterals
    Process Development
    Process Validation
    Risk Management
    Scale-up/ Technology Transfer
    Solid Dosage/ Creams/ Ointments

    AGC Biologics Expands Cell and Gene Facility in Italy

    Celonic to Boost Cell & Gene Therapy Production

    Pharmaron Acquires Biomanufacturing Site in the UK from AbbVie

    Fujifilm Breaks Ground on Major Expansion of Biologics Facility in Denmark

    Reed-Lane Facility Virtual Tour
    Capsules
    Cold Chain Management
    Injectables
    Logistics
    Serialization
    Solid Dosage / Semi-solids
    Supply Chain
    Vials

    Reed-Lane Facility Virtual Tour

    Hygienic Packaging Technology

    Reshaping the Pharmaceutical Supply Chain

    Serialization: Level 5 Solution

    Covectra Introduces Next-Gen Serialization Solution
    Analytical Services
    Bioanalytical Services
    Bioassay Developement
    Biologics, Proteins, Vaccines
    Biosimilars
    Chemistry
    Clinical Trials
    Drug Delivery
    Drug Development
    Drug Discovery
    Formulation Development
    Information Technology
    Laboratory Testing
    Methods Development
    Microbiology
    Preclinical Outsourcing
    R&D
    Toxicology

    Data Management Trends

    AGC Biologics Expands Cell and Gene Facility in Italy

    Celonic to Boost Cell & Gene Therapy Production

    Pharmaron Acquires Biomanufacturing Site in the UK from AbbVie

    Aptamer Extends Collaboration with AstraZeneca
    Filtration & Purification
    GMPs/GCPs
    Inspections
    QA/QC
    Regulatory Affairs
    Validation

    Guide to Maintaining Validation of Older Facilities: Why, When and How

    The Year of COVID: How FDA Coped with a Worldwide Pandemic in 2020 and What to Expect in 2021

    Top BioPharma Form Accumulus Synergy

    Global Biosciences Co. Selects ValGenesis VLMS

    Gene Therapy Co. Selects ValGenesis' SaaS Platform
    Companies
    Categories
    Corporate Capabilities
    Add New Company
    Contract Service Directory Companies
    Baxter BioPharma Solutions

    Adare Pharma Solutions

    Almac Group

    Emergent BioSolutions

    Cytovance Biologics
    Companies
    News Releases
    Posters
    Brochures
    Services
    Videos
    Case Study
    White Papers
    Jobs
    Contract Service Directory Companies
    Cytovance Biologics

    Emergent BioSolutions

    Syngene

    Alcami

    PCI Pharma Services
    Webinars
    Live From Shows
    • Magazine
      • Current / Back Issue
      • Features
      • Editorial
      • Columns
      • Editorial Guidelines
      • Subscribe Now
      • Advertise Now
      • Enewsletter Archive
      • Digital Edition
    • Directory
      • Companies
      • Categories
      • Corporate Capabilities
      • Add Your Company
    • Manufacturing
      • APIs
      • Aseptic Processing
      • Cleaning Validation
      • Clinical Trial Materials
      • Cytotoxics and High Potency Manufacturing
      • Equipment
      • Excipients
      • Extractables and Leachables
      • Facilities
      • Fill/Finish
      • Lyophilization
      • Parenterals
      • Process Development
      • Process Validation
      • Risk Management
      • Scale-up/ Technology Transfer
      • Solid Dosage/ Creams/ Ointments
      • cGMP Manufacture
    • Packaging
      • Capsules
      • Cold Chain Management
      • Injectables
      • Logistics
      • Serialization
      • Solid Dosage / Semi-solids
      • Supply Chain
      • Vials
    • Development
      • Analytical Services
      • Bioanalytical Services
      • Bioassay Developement
      • Biologics, Proteins, Vaccines
      • Biosimilars
      • Chemistry
      • Clinical Trials
      • Drug Delivery
      • Drug Development
      • Drug Discovery
      • Formulation Development
      • Information Technology
      • Laboratory Testing
      • Methods Development
      • Microbiology
      • Preclinical Outsourcing
      • R&D
      • Toxicology
    • Compliance
      • Filtration & Purification
      • GMPs/GCPs
      • Inspections
      • QA/QC
      • Regulatory Affairs
      • Validation
    • Top 25 Pharma & BioPharma
    • Contract Pharma Direct
    • Breaking News
    • Online Exclusives
    • Slideshows
    • Experts Opinions
    • Surveys
      • Outsourcing Survey
      • Salary Survey
    • Glossary
    • Videos
    • Podcasts
    • White Papers
    • Infographics
    • Contract Pharma Conference
      • Contract Pharma Conference
      • Speakers
      • Exhibitors
      • Conference Sessions
    • Supplier Microsite
      • Companies
      • News Releases
      • Posters
      • Brochures
      • Services
      • Videos
      • Case Study
      • White Papers
    • eBook
    • Webinars
    • Events
      • Industry Events
      • Live from Show Events
      • Webinars
    • Classifieds / Job Bank
      • Classifieds
      • Job Bank
    • About Us
      • About Us
      • Contact Us
      • Advertise With Us
      • Privacy Policy
      • Terms of Use
    Pharma Beat

    Blackberry Wine: Could it Help Your Diabetes?

    Recent research points towards the positive impact ‘berry wine’ might have on diabetes

    Related CONTENT
    • Tackling TB Resistance
    • Allergan and Novartis in Clinical Collaboration
    • Could Nuts Ward Off Cancer?
    • The Trials and Tribulations of Male Contraception
    • Financial Report: Johnson & Johnson
    Adele Graham-King, Contributing Editor10.11.16
    It is widely recognized that type 2 diabetes is the result of poor diet and not enough exercise, resulting in obesity and a metabolic shift towards insulin resistance and poor glucose control. Now almost endemic in the Western world, it is also becoming more and more of an issue in developing countries because of these very same issues as processed foods continue to make up a large part our diets and technology-related hobbies replace physical activity, leading to the prevalence of sedentary life styles.

    Primary treatment for type 2 diabetes is through management of these variables—combining weight loss and exercise, moderating the intake of high calorie, fatty, sugary and salty foods as well as decreasing alcohol intake. The difficult part of self-management is the adherence to life-style changing regimens, which often results in failure to treat and the introduction of pharmaceutical agents, metformin being the most common.

    One of the fundamental influences over both weight and glucose control is diet, and if this is managed effectively it’s a great assistance on the road to effective blood glucose control. Berries are one of the foods strongly advocated by physicians across the board. However, although they are touted because they are low in carbohydrates and patients can generally eat large portions of them, hard scientific evidence relating to any proven medicinal benefit is difficult to find. Experts believe they may well have therapeutic properties beyond simply having a positive impact on weight management.

    Blackberries, blueberries and other berries contain chemical compounds in their skins, which have been researched for their potential influence on glucose control and insulin sensitivity. These berries contain anthocyanins, the red, blue and purple pigments that color the skins of the different berries depending on their pH. There is a theory that the anthocyanins may also act as antioxidants. However, due to their physiological placement their ability to scavenge free radicals may be limited because they are located remotely from metabolically active locations.

    The ‘super food’ status that these berries carry has created a large amount of research interest in them for their potential ability to influence disease states. The University of Illinois recently presented research results indicating that a ‘tonic’ made from fermented berries, minus the alcohol, creates a berry ‘wine’ that might have an enhanced impact on diabetic markers such as hyperglycemia, while also improving insulin sensitivity and secretion in mice.

    Previous research has shown that fermenting berries of various varieties can increase the concentration and availability of anthocyanins—blanching berries can also have a similar effect. It is also recognized that blueberries can have an impact on glycemic control in mice, and there has also been indication that these little gems may improve insulin sensitivity in human subjects too.

    The research team at the University of Illinois had already illustrated in-vitro that a dealcoholized concoction could reduce the activity of glucose absorbing enzymes, and moved to an in-vivo study. The work, which was headed up by Elvira de Mejia, a food scientist based in the Department of Food Science and Human Nutrition, employed a wine consisting of 70% fermented blackberries and 30% fermented blueberries as the medicine. Following fermentation, the alcohol was removed from the solution alongside some of the remaining sugars and then watered down. Different concentrations of the drink were prepared, containing differing amounts of anthocyanins (0.1x, 1x and 2x). Blackberries are known to contain the highest concentrations of antioxidants and anthocyanins compared to all other fruits, and the combination of blackberries with blueberries is a wise combination for creating concentrated anthocyanin potions.

    The ‘super wine’ was administered to mice, which had diet-induced obesity and hyperglycemia—a comparator to many type 2 diabetic humans. They were randomized into groups for the 3 different wine concentrations, as well as into a group given sitagliptin and a control placebo group. All dietary intake, calories and sugar were controlled throughout the investigation.

    The researchers found that in all the groups who drank the berry wine there was a beneficial effect on the diabetic markers. However, in the group who were fed the strongest tonic there was the most dramatic improvement. In addition, this particular group of mice showed no weight gain at all. Although this wasn’t set as an end-point of the study, it is an interesting observation, especially bearing in mind one of the primary causes of type 2 diabetes is lack of weight control and weight gain.

    Upon tissue investigation, the investigators found that much more glucose had been taken up into the tissues than remained circulating in the blood, and this was consistent across the groups taking the differing concentrations of the berry wine. All these results point to the fact that the antioxidant effect is strong, potentially providing a protective effect on the DNA of the cells. There were other anti-inflammatory benefits observed in all the berry wine groups, but as all the pathways are metabolically linked, this isn’t a surprise. However, this does give rise to an additional route of investigation into the super power of these fruits.

    The true reality is that this research probably has more relevance to the wine manufacturing industry in the near future than anything else. Creating good tasting alcohol-free wine is something that the wine industry has struggled with over the years, and although it is commercially available, it doesn’t always taste the best. The other thing to bear in mind from a medicinal viewpoint is that anthocyanins are only found in the skins of berries, and because the fermentation process of white wine doesn’t include the use of the skins, any beneficial effect will only be seen with the red variety.

    Although we’re some way off from being able to scientifically state that it’s possible to treat diabetes with blackberries and blueberries, for anyone with a pre-disposition, obesity, hyperglycemia or insulin resistance, it might not be a bad idea to make a blackberry/blueberry smoothie every now and then, rather than a chocolate shake.
    Harnessing the power of anthocyanins and encapsulating them in an alcohol-free wine may well be the future of enhanced type 2 diabetes treatment combined with traditional pharmaceutical therapies. In the interim, for those of us who are fortunate enough to be healthy, I’d suggest a nice large glass of red.


    Adele Graham-King
    Contributing Editor

    Adele is a design consultant who works in product development for medical and healthcare applications. Her background is in pharma, and she has a degree in applied physiology
    Related Searches
    • R&D
    • Drug Discovery
    • Drug Development
    Suggested For You
    Tackling TB Resistance Tackling TB Resistance
    Allergan and Novartis in Clinical Collaboration Allergan and Novartis in Clinical Collaboration
    Could Nuts Ward Off Cancer? Could Nuts Ward Off Cancer?
    The Trials and Tribulations  of Male Contraception The Trials and Tribulations of Male Contraception
    Financial Report: Johnson & Johnson Financial Report: Johnson & Johnson
    ‘Smart’ Heparin Delivery Could Self-Modulate ‘Smart’ Heparin Delivery Could Self-Modulate
    Evotec, Eternygen to Develop Metabolic Disease Therapy Evotec, Eternygen to Develop Metabolic Disease Therapy
    Is Nicotine Such a ‘Bad Boy’? Is Nicotine Such a ‘Bad Boy’?
    Allergan to Acquire Tobira Therapeutics Allergan to Acquire Tobira Therapeutics
    Melior, Bukwang Partnership Reaches Milestone Melior, Bukwang Partnership Reaches Milestone
    ANI Acquires Inderal LA Assets ANI Acquires Inderal LA Assets
    Filament BioSolutions, Ajinomoto Form Partnership Filament BioSolutions, Ajinomoto Form Partnership
    PharmaCyte Biotech Enters Research and Consulting Agreements with University of Technology Sydney PharmaCyte Biotech Enters Research and Consulting Agreements with University of Technology Sydney
    Hi-Tech Acquires APN Hi-Tech Acquires APN
    FDA Approves Sanofi’s Toujeo FDA Approves Sanofi’s Toujeo

    Related Pharma Beat

    • Drug Development

      NSAIDs – Friend or Foe?

      Although widely used for years, NSAIDs have side effects that could eventually change their OTC status
      Adele Graham-King, Contributing Editor 06.06.17

    • Drug Development | Drug Discovery
      Tackling TB Resistance

      Tackling TB Resistance

      The TB Alliance is partnering with universities, government agencies, public agencies and a small number of pharma compani
      Adele Graham-King, Contributing Editor 05.09.17

    • Drug Development

      Could Nuts Ward Off Cancer?

      Recent research looks into the anti-cancer properties of various nuts
      Adele Graham-King, Contributing Editor 04.03.17


    • Drug Delivery | Drug Development | R&D

      ‘Smart’ Heparin Delivery Could Self-Modulate

      A group of researchers have spent the past two years investigating self-controlling dosing and monitoring systems
      Adele Graham-King, Contributing Editor 01.26.17

    • Drug Development | Drug Discovery | R&D

      Is Nicotine Such a ‘Bad Boy’?

      Investigating this controversial compound’s potential health benefits
      Adele Graham-King, Contributing Editor 11.09.16

    • Chemistry | Drug Development
      Anyone Fancy a Beer?

      Anyone Fancy a Beer?

      The centuries-old brew continues to be investigated for its medicinal properties
      Adele Graham-King, Contributing Editor 05.05.16


    • Drug Development

      Chipping Away at the Old Cancer Block

      Advances in cancer treatment continue to march towards finding a cure
      Adele Graham-King, Contributing Editor 04.05.16

    • Clinical Trials | Drug Development

      The 3D Printed Pill

      It’s the future…or is it?
      Adele Graham-King, Contributing Editor 01.28.16

    • Clinical Trials | Drug Development | Drug Discovery | R&D

      Are We There Yet?

      Many promising cancer treatments are on the horizon
      Adele Graham-King, Contributing Editor 07.14.15


    • APIs | Bioassay Development | Drug Development | Methods Development | Process Development | Toxicology

      The Last Chance Saloon?

      Looking at the pharmaceutical ‘diet’ of anti-obesity drugs
      Adele Graham-King, Contributing Editor 06.02.15

    • Clinical Trials | Drug Development

      100 New Drugs in 10 Years?

      Repurposing drug candidates that never saw the light of day
      Adele Graham-King, Contributing Editor 03.06.15

    • APIs | Bioassay Development | Clinical Trials | Drug Development | Drug Discovery | Methods Development | Process Development | R&D | Toxicology

      Experimental Drugs

      To use or not to use unlicensed drugs? That is the question.
      Adele Graham-King, Contributing Editor 01.29.15


    • Drug Delivery | Drug Development
      The End of a Century

      The End of a Century

      Looking at 15 years of pharmaceutical evolution.
      Adele Graham-King 10.14.14

    • Drug Discovery

      Under the Sea: The Search for New Cures in the “Post-Antibiotic” Era

      A new WHO report raises some frightening questions on antimicrobial resistance, while Scotland’s PharmaSea Project looks for answers in the oceans’ depths
      Adele Graham-King 07.21.14

    • Chemistry | Drug Discovery | Supply Chain

      Toward a Process-Centered Pharma

      Saying “No” to change is normal, but adopting true QbD practices could save the industry about 20-25% of its global revenue and allow pharma to add two to three billion patients to its customer base
      Girish Malhotra, EPCOT International 06.03.14

    Trending
    • Catalent Acquires Delphi Genetics
    • Four Female Leaders Appointed To Cell & Gene CDMO
    • Matica Biotechnology Breaks Ground On Cell And Gene Therapy Site
    • Celonic Group Announces Plans For New Facility In Switzerland
    • BMS Expands Cell Therapy Manufacturing Capabilities
    Breaking News
    • AGC Biologics Expands Cell and Gene Facility in Italy
    • Celonic to Boost Cell & Gene Therapy Production
    • Pharmaron Acquires Biomanufacturing Site in the UK from AbbVie
    • Aptamer Extends Collaboration with AstraZeneca
    • Fujifilm Breaks Ground on Major Expansion of Biologics Facility in Denmark
    View Breaking News >
    CURRENT ISSUE

    March 2021

    • Hygienic Packaging Technology
    • Trends in Solid Oral Dosage Delivery
    • 5 Reasons Paper Has No Place in Contract Manufacturing
    • Injectable Drug Delivery Trends
    • Pharmaceutical Manufacturing Equipment Trends
    • Oral Solids: Market & Technology Trends
    • Nutraceutical Manufacturing: Meeting the Challenges of Today, Planning for Tomorrow
    • 2021 Contract Manufacturing Survey
    • Small Molecule Development Trends
    • Challenges & Opportunities Facing Small & Emerging Biopharma Companies
    • View More >

    Cookies help us to provide you with an excellent service. By using our website, you declare yourself in agreement with our use of cookies.
    You can obtain detailed information about the use of cookies on our website by clicking on "More information”.

    • About Us
    • Privacy Policy
    • Terms And Conditions
    • Contact Us

    follow us

    Subscribe
    Nutraceuticals World

    Latest Breaking News From Nutraceuticals World

    Thymoquinone Inhibits Viral Infection in In Vitro Settings, New Study Finds
    IFT Transitions 2021 Annual Event to Digital Experience
    NY Federal Judge Enters Permanent Injunction Against Dietary Supplement Manufacturer
    Coatings World

    Latest Breaking News From Coatings World

    Sherwin-Williams Announces Resignation of President and COO
    Ashland Completes Expansion and Relocation of Viatel Bioresorbable Polymers Manufacturing Facility
    Evonik Receives Sustainability Award from EcVadis
    Medical Product Outsourcing

    Latest Breaking News From Medical Product Outsourcing

    Cretex CFO Announces Retirement
    New AI-Based Tool Developed for Coronary Artery Analysis, Intervention Planning
    First Reported Use of Pulse Biosciences' CellFX System
    Contract Pharma

    Latest Breaking News From Contract Pharma

    AGC Biologics Expands Cell and Gene Facility in Italy
    Celonic to Boost Cell & Gene Therapy Production
    Pharmaron Acquires Biomanufacturing Site in the UK from AbbVie
    Beauty Packaging

    Latest Breaking News From Beauty Packaging

    Ulta Beauty Opens in Herald Square
    Elizabeth Arden Taps Sui He as Global Brand Ambassador
    Natura &Co Outperforms the Global Market in Q4 2020
    Happi

    Latest Breaking News From Happi

    Dr. Sheffield’s Adds New Toothpaste Flavors
    First Two Hand Sanitizers Are Certified by Green Seal
    Elizabeth Arden Taps Supermodel and Actress Sui He
    Ink World

    Latest Breaking News From Ink World

    Massilly North America Adds Koenig & Bauer MetalStar 3 Metal Decorating Press
    Hydrocarbon Solvents Market to Surpass $8.1 Billion by 2030
    Access Direct Mail Doubles Revenue with SCREEN's Truepress Jet520HD
    Label & Narrow Web

    Latest Breaking News From Label & Narrow Web

    Arjobex America welcomes Maggie Naberezny to sales team
    Henkel publishes 30th Sustainability Report
    Avery Dennison Smartrac launches new Circus Pro inlays
    Nonwovens Industry

    Latest Breaking News From Nonwovens Industry

    FPInnovations Develops Biodegradable Mask
    Sani Professional Sanitizing and Disinfecting Products Approved by EPA
    Autefa Solutions Offers Fully Automated Line for Protective Mask Production
    Orthopedic Design & Technology

    Latest Breaking News From Orthopedic Design & Technology

    Colfax Decides to Divide Its Businesses
    Stryker Corp.'s 2020 Sales Slip 3.6 Percent
    Bioventus Appoints Managing Director, China and Asia Pacific
    Printed Electronics Now

    Latest Breaking News From Printed Electronics Now

    Comercial Kywi Improves Customer Service, Front-Store Operations with Zebra Mobile Solution
    Global Printed Circuit Board Market Projected to Reach $69.32 Billion by 2027
    Global Smart Glass Market to Register 6.8% CAGR Between 2021-28: Grand View Research

    Copyright © 2021 Rodman Media. All rights reserved. Use of this constitutes acceptance of our privacy policy The material on this site may not be reproduced, distributed, transmitted, or otherwise used, except with the prior written permission of Rodman Media.

    AD BLOCKER DETECTED

    Our website is made possible by displaying online advertisements to our visitors.
    Please consider supporting us by disabling your ad blocker.


    FREE SUBSCRIPTION Already a subscriber? Login